Results

Total Results: 9 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

  1. srdr.ahrq.gov/projects/1705/studies/197218
    January 01, 2007 - Cancel Study Preview Study Title and Description Efficacy and safety … of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized … Comments ( 0 ) | Post/View Title Data Title Efficacy and safety … of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized
  2. srdr.ahrq.gov/projects/1705/studies/197198
    January 01, 2017 - Cancel Study Preview Study Title and Description Efficacy and safety … of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients … Comments ( 0 ) | Post/View Title Data Title Efficacy and safety … of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients
  3. srdr.ahrq.gov/projects/1705
    December 04, 2020 - H., Berg T., Wiegand J. 2015 Lamivudine treatment in HBeAg-negative chronic hepatitis B patients … Chow WC., Paik SW., Chang WY., Berg T., Flisiak R., McCloud P., Pluck N. 2005 Efficacy and safety … of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients … Yalçin K., Değertekin H., Kokoğlu OF., Ayaz C. 2004 Efficacy and safety of entecavir compared … to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial
  4. srdr.ahrq.gov/projects/1565
    sleep and breathing as surrogates (or intermediate outcomes) for clinically significant outcomes in patients … former and the latter, and (2) synthesize evidence on the (comparative) efficacy, effectiveness and safety … The SR will attempt to describe heterogeneity of treatment effects in terms of diversity of patient populations … with OSA, healthcare policy makers, and patients. … Lazzeroni LC., Fairchild JK., Friedman L., Sekhon G., Thompson S., Cheng J., Zeitzer JM. 2014 Patient-reported
  5. srdr.ahrq.gov/projects/1520
    January 01, 2014 - Of note, this review will not evaluate the need for, or the choice of, surgery for the patient with acute … • Do the effects and harms vary by patient characteristics, presentation or course of illness, or other … • Do the (comparative) effects and harms vary by patient characteristics, course of illness, or other … Aquina CT., Becerra AZ., Xu Z., Justiniano CF., Noyes K., Monson JRT., Fleming FJ. 2019 Applicability, safety … Spila Alegiani S., Chiesara F., Moretti A., Bianchi M., Dezi A., Traversa G., Koch M. 2017 Long-term safety
  6. srdr.ahrq.gov/projects/1709/
    October 11, 2021 - systems can implement to reduce length of stay (LOS), with emphasis on medically complex or vulnerable patients … 2016 A systematic review and meta-analysis evaluating geriatric consultation on older trauma patients … Boonen S., Gosset C., Petermans J., Milisen K. 2010 Interventions designed to improve the safety … Austin J., Barras M., Sullivan C. 2020 Systematic review of interventions to improve safety … BE., Beveridge I., Athanasiou T., Wachter RM., Sevdalis N. 2015 Does case management for patients
  7. srdr.ahrq.gov/projects/1712
    April 05, 2021 - Patient characteristics? … Patient characteristics? … Patient characteristics? … Patient characteristics? … Hardy GB., Maddry JK., Ng PC., Savell SC., Arana AA., Kester A., Bebarta VS. 2018 Safety
  8. srdr.ahrq.gov/projects/1312
    March 09, 2019 - oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients … 1996 Low vs. higher-dose dark chocolate and blood pressure in cardiovascular high-risk patients … Novotny JA., Baer DJ., Khoo C., Gebauer SK., Charron CS. 2015 Safety and efficacy of cocoa … Green tea extract decreases plasma malondialdehyde concentration but does not affect other indicators … K. 2015 A Randomized, Placebo-Controlled Study on the Safety and Efficacy of Daily Ingestion
  9. srdr.ahrq.gov/projects/1596
    November 22, 2019 - In most pharmacotherapy trials, drug use counseling was provided to all patients. … is identified through primary care-based screening is uncertain, intervention trials that enrolled patients … In most pharmacotherapy trials, drug use counseling was provided to all patients. … CA., Meli SM., Chaisson CE., Samet JH. 2014 Brief intervention for problem drug use in safety-net … for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: